GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (OTCPK:ELIXF) » Definitions » Cyclically Adjusted Price-to-FCF

Elixxer (Elixxer) Cyclically Adjusted Price-to-FCF : (As of Jun. 10, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Elixxer Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Elixxer Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Elixxer's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixxer Cyclically Adjusted Price-to-FCF Chart

Elixxer Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Elixxer Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Elixxer's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Elixxer's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixxer's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixxer's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Elixxer's Cyclically Adjusted Price-to-FCF falls into.



Elixxer Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Elixxer's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Elixxer's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.003/125.2304*125.2304
=-0.003

Current CPI (Sep. 2023) = 125.2304.

Elixxer Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201306 0.230 97.182 0.296
201309 -0.062 97.419 -0.080
201312 -0.091 96.945 -0.118
201403 -0.100 98.604 -0.127
201406 -0.575 99.473 -0.724
201409 -0.192 99.394 -0.242
201412 -0.143 98.367 -0.182
201503 -0.118 99.789 -0.148
201506 -0.179 100.500 -0.223
201509 -0.055 100.421 -0.069
201512 -0.099 99.947 -0.124
201603 -0.071 101.054 -0.088
201606 -0.221 102.002 -0.271
201609 0.000 101.765 0.000
201612 -0.155 101.449 -0.191
201703 -0.174 102.634 -0.212
201706 -0.076 103.029 -0.092
201709 -0.471 103.345 -0.571
201712 -0.328 103.345 -0.397
201803 -0.210 105.004 -0.250
201806 -0.309 105.557 -0.367
201809 -0.260 105.636 -0.308
201812 -0.295 105.399 -0.351
201903 -0.317 106.979 -0.371
201906 -0.243 107.690 -0.283
202003 -0.112 107.927 -0.130
202006 0.031 108.401 0.036
202009 -0.138 108.164 -0.160
202012 -0.168 108.559 -0.194
202103 -0.142 110.298 -0.161
202106 -0.088 111.720 -0.099
202109 -0.058 112.905 -0.064
202112 -0.096 113.774 -0.106
202203 -0.028 117.646 -0.030
202206 -0.123 120.806 -0.128
202209 -0.056 120.648 -0.058
202212 -0.003 120.964 -0.003
202303 -0.103 122.702 -0.105
202306 -0.044 124.203 -0.044
202309 -0.003 125.230 -0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Elixxer  (OTCPK:ELIXF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Elixxer Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Elixxer's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixxer (Elixxer) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1100 Boulevard Rene- Levesque Ouest, Suite 700, Montreal, QC, CAN, H5B 4N4
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.